Expression of Human epidermal growth factor receptor 2, Survivin, Enhancer of zeste homolog -2, Cyclooxygenase-2, p53 and p16 molecular markers in Gall bladder carcinoma
Gastric cancer review
Lauren Peirce CarcasDepartment of Hematology and Oncology, Sylvester Comprehensive Cancer Center, Miami, Florida 33136, USA.DOI: 10.4103/1477-3163.146506 ABSTRACT Gastric cancer is ...
Read More
Expression of Human epidermal growth factor receptor 2, Survivin, Enhancer of zeste homolog -2, Cyclooxygenase-2, p53 and p16 molecular markers in Gall bladder carcinoma
The advent of precision therapy in gastrointestinal malignancies: Targeting the human epidermal growth factor receptor family in colorectal and esophagogastric cancer
Danielle Desautels1, Craig Harlos1, Piotr Czaykowski21Department of Internal Medicine, University of Manitoba, Winnipeg, MB R3E 0V9, Canada.2Department of Internal Medicine, ...
Read More
Expression of Human epidermal growth factor receptor 2, Survivin, Enhancer of zeste homolog -2, Cyclooxygenase-2, p53 and p16 molecular markers in Gall bladder carcinoma
Reducing inequities in colorectal cancer screening in North America
Kathleen M Decker1, Harminder Singh21Department of Community Health Sciences, University of Manitoba; Screening Programs, Cancer Care Manitoba, Canada2Department of Community ...
Read More
Expression of Human epidermal growth factor receptor 2, Survivin, Enhancer of zeste homolog -2, Cyclooxygenase-2, p53 and p16 molecular markers in Gall bladder carcinoma
Esophageal cancer: Recent advances in screening, targeted therapy, and management
Puja Gaur1, Min P Kim1, Brian J Dunkin21Department of Thoracic; Department of General Surgery, Weill Cornell Medical College of Cornell ...
Read More
Histological images of the colonic mucosa of azoxymethane
Doenjang prepared with mixed starter cultures attenuates azoxymethane and dextran sulfate sodium-induced colitis-associated colon carcinogenesis in mice
Ji-Kang Jeong1, Hee-Kyung Chang2, Kun-Young Park11Department of Food Science and Nutrition, Pusan National University, Busan 609-735, Korea.2Department of Pathology, Kosin ...
Read More
Can 2009 herald a new era in preventing cervical cancers?
Circulating tumor cells in breast cancer
Geetha Pukazhendhi1, Stefan Gl├╝ck21Department of Medicine, Hematology Oncology Division, Miller School of Medicine, Miami, FL, USA2Department of Medicine, Hematology Oncology ...
Read More
Inhibitory potential of methanolic extracts of Aristolochia tagala and Curcuma caesia on hepatocellular carcinoma induced by diethylnitrosamine in BALB/c mice
Inhibitory potential of methanolic extracts of Aristolochia tagala and Curcuma caesia on hepatocellular carcinoma induced by diethylnitrosamine in BALB/c mice
Khetbadei Lysinia Hynniewta Hadem1, Rajeshwar Nath Sharan2, Lakhan Kma31Cancer and Radiation Countermeasures Unit; Radiation and Molecular Biology Unit, Department of ...
Read More
Expression of Human epidermal growth factor receptor 2, Survivin, Enhancer of zeste homolog -2, Cyclooxygenase-2, p53 and p16 molecular markers in Gall bladder carcinoma
Novel agents in the management of castration resistant prostate cancer
Shruti Chaturvedi1, Jorge A Garcia21Department of Internal Medicine, Cleveland Clinic, Taussig Cancer Institute and Glickman Urological and Kidney Institute, Cleveland, ...
Read More
Systems oncology: A new paradigm in cancer research
Systems oncology: A new paradigm in cancer research
Gopala KovvaliEditor-in-Chief, Journal of Carcinogenesis, Adjunct Professor, Graduate School of Biomedical Sciences, UNTHSC, Fort Worth, TX, USADOI: 10.4103/1477-3163.128641 ABSTRACT Since ...
Read More
Expression of Human epidermal growth factor receptor 2, Survivin, Enhancer of zeste homolog -2, Cyclooxygenase-2, p53 and p16 molecular markers in Gall bladder carcinoma
Targeted therapy for renal cell carcinoma: The next lap
Ravindran Kanesvaran1, Min-Han Tan21Department of Medical Oncology, National Cancer Centre Singapore, Singapore 169610, Singapore2Department of Medical Oncology, National Cancer Centre ...
Read More
Expression of Human epidermal growth factor receptor 2, Survivin, Enhancer of zeste homolog -2, Cyclooxygenase-2, p53 and p16 molecular markers in Gall bladder carcinoma
BRAF and beyond: Tailoring strategies for the individual melanoma patient
Anthony Jarkowski1, Nikhil I Khushalani21Department of Pharmacy, James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, USA2Department of ...
Read More
Antisense oligonucleotides directed against insulin-like growth factor-II messenger ribonucleic acids delay the progress of rat hepatocarcinogenesis
Antisense oligonucleotides directed against insulin-like growth factor-II messenger ribonucleic acids delay the progress of rat hepatocarcinogenesis
Miltu Kumar Ghosh1, Falguni Patra2, Shampa Ghosh2, Chowdhury Mobaswar Hossain2, Biswajit Mukherjee21Department of Pharmaceutical Technology, Jadavpur University, Kolkata, West Bengal, ...
Read More
Targeted therapy in gastrointestinal malignancies
Targeted therapy in gastrointestinal malignancies
Ravi Chhatrala1, Yasmin Thanavala2, Renuka Iyer31Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University, Richmond, VA, USA2Department ...
Read More